Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12609000635268
Ethics application status
Not yet submitted
Date submitted
23/07/2009
Date registered
29/07/2009
Date last updated
29/07/2009
Type of registration
Prospectively registered

Titles & IDs
Public title
An investigation of a gel dressing on the tonsillectomy fossa to relieve post-tonsillectomy pain.
Scientific title
An investigation into post-operative pain in tonsillectomy patients with antibiotic-steroid gel applied to the tonsillectomy fossa compared to patients without the gel.
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Post-tonsillectomy pain 237344 0
Condition category
Condition code
Surgery 239665 239665 0 0
Surgical techniques

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Antibiotic-steroid gel applied to tonsillectomy fossaeonce only during tonsillectomy.Exact formula of gel subject to patent application but has been disclosed to Belberry Ethics committee and TGA for approval.
Intervention code [1] 237005 0
Treatment: Drugs
Comparator / control treatment
Post-tonsillectomy patients without gel
Control group
Active

Outcomes
Primary outcome [1] 238439 0
To assess if gel reduces post-operative pain assessed by visual analogue scale(smiley face 1-10) commomly used to assess post-operative tonsillectomy pain.
Timepoint [1] 238439 0
5 days post-operatively.
Secondary outcome [1] 244941 0
Any increase in secondary haemorrhage as reported by patient(any bleeding from the tonsil fossa,how long the bleeding lasts and whether return to operating theatre is required).
Timepoint [1] 244941 0
Within 2 to 3 weeks of surgery

Eligibility
Key inclusion criteria
All patients having tonsillectomy above 5 years of age.
Minimum age
5 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Children less than 5 years old.

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Discussion pre-operatively with patient or parents.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Non-randomised trial
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Phase 3 / Phase 4
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 237388 0
Self funded/Unfunded
Name [1] 237388 0
Dr.Chris Dalton
Country [1] 237388 0
Australia
Primary sponsor type
Individual
Name
Dr.Chris Dalton
Address
Suite 18
Children's Hospital Medical Centre
Hainsworth St.
Westmead NSW 2145
Country
Australia
Secondary sponsor category [1] 236888 0
None
Name [1] 236888 0
Address [1] 236888 0
Country [1] 236888 0

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 239520 0
Ethics committee address [1] 239520 0
Ethics committee country [1] 239520 0
Date submitted for ethics approval [1] 239520 0
31/07/2009
Approval date [1] 239520 0
Ethics approval number [1] 239520 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 29957 0
Address 29957 0
Country 29957 0
Phone 29957 0
Fax 29957 0
Email 29957 0
Contact person for public queries
Name 13204 0
Dr.Chris Dalton
Address 13204 0
Suite 18
Children's Hospital Medical Centre
Hainsworth St.
Westmead NSW 2145
Country 13204 0
Australia
Phone 13204 0
61 2 9633 2133
Fax 13204 0
61 2 9633 2515
Email 13204 0
cjgj@bigpond.net.au
Contact person for scientific queries
Name 4132 0
Dr.Chris Dalton
Address 4132 0
Suite 18
Children's Hospital Medical Centre
Hainsworth St.
Westmead NSW 2145
Country 4132 0
Australia
Phone 4132 0
61 2 9633 2133
Fax 4132 0
61 2 9633 2515
Email 4132 0
cjgj@bigpond.net.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.